Bright Health Group Q3 FY22: revenue $1.6B; diluted EPS −$40.00

Key figures from this report

These are the numbers Bright Health Group reported for Q3 FY22, the quarter ended Sep 30, 2022, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

1. Revenue$1.6BNo year-earlier figure tagged10-Q income statement, on EDGAR
2. Net income−$306.1MNo year-earlier figure tagged10-Q income statement, on EDGAR
3. Diluted EPS−$40.00No year-earlier figure tagged. Split-adjusted, as the tables show it; the filing reported −$0.5010-Q income statement, on EDGAR
4. Cash and cash equivalents$1.6BNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
5. Cash from operations−$614.9MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters